Ge Healthcare Technologies INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
William K Grogan, Chief Financial Officer of GE HealthCare Technologies Inc., reported multiple transactions in common stock on September 14, 2026.
NASDAQ
Philip Rackliffe, CEO, AIS of GE HealthCare Technologies Inc., reported a transaction in 798 shares of common stock on September 3, 2026.
NASDAQ
Kevin Michael O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reported a transaction in 718 shares of common stock on September 3, 2026.
NASDAQ
George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reported a transaction in 112 shares of common stock on September 3, 2026.
NASDAQ
Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., reported a transaction in 1,502 shares of common stock on September 3, 2026.
NASDAQ
Frank R Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reported a transaction in 1,480 shares of common stock on September 3, 2026.
NASDAQ
Adam Y Holton, Chief People Officer of GE HealthCare Technologies Inc., reported a transaction in 673 shares of common stock on September 3, 2026.
NASDAQ
Catherine Estrampes, Chief Commer. & Growth Officer of GE HealthCare Technologies Inc., reported a transaction in 508 shares of common stock on September 3, 2026.
NASDAQ
Peter J Arduini, President and CEO and a Director of GE HealthCare Technologies Inc., reported a transaction in 6,303 shares of common stock on September 3, 2026.
NASDAQ
GE HealthCare Technologies Inc. reports a Form 4 filing detailing a Director's acquisition of common stock.
NASDAQ
Jeannette Bankes, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reported a transaction involving the sale of 5,535 shares of common stock.
NASDAQ
GE HealthCare Technologies Inc. director Rodney F. Hochman reported the acquisition of 1,618 shares of common stock on May 12, 2026.
NASDAQ
GE HealthCare Director Phoebe L. Yang acquired 4,586 shares through a combination of an RSU grant and open market purchases.
NASDAQ
GE HealthCare Technologies Inc. director H. Lawrence Culp Jr. acquired 7,743 shares through restricted and deferred stock unit awards.
NASDAQ
GE HealthCare Technologies Inc. director Rodney F. Hochman acquired 6,275 shares through restricted and deferred stock unit awards.
NASDAQ
Director Catherine Lesjak was granted 3,586 restricted stock units as part of GE HealthCare Technologies Inc. compensation.
NASDAQ
Director Kevin Lobo acquired 3,586 restricted stock units in GE HealthCare Technologies Inc. as part of a standard equity grant.
NASDAQ
Director Anne T. Madden acquired 5,868 shares of GE HealthCare common stock through restricted and deferred stock unit awards.
NASDAQ
GE HealthCare Technologies Inc. director William J. Stromberg was granted 3,586 restricted stock units as part of director compensation.
NASDAQ
GE HealthCare Technologies Inc. reports a Form 4 filing detailing a stock purchase by Director William J. Stromberg.
NASDAQ
GE HealthCare Technologies Inc. CFO James Saccaro purchased 3,310 shares of common stock at an average price of $60.5997.
NASDAQ
GE HealthCare Technologies Inc. President and CEO Peter J. Arduini purchased 4,169 shares of common stock.
NASDAQ
GE HealthCare Technologies Inc. Director Kevin Lobo received an award of 777 restricted stock units, vesting by March 2027, aligning his interests with shareholders.
NASDAQ
GE HealthCare Technologies Inc.'s CEO of Patient Care Solutions, Jeannette Bankes, was granted 6,861 restricted stock units and 18,038 employee stock options.
NASDAQ
GE HealthCare Technologies Inc.'s General Counsel, Frank R. Jimenez, was granted 10,915 restricted stock units and 28,697 employee stock options.
NASDAQ
GE HealthCare Technologies Inc.'s Chief Technology Officer, Taha Kass-Hout, received awards of restricted stock units and employee stock options.
NASDAQ
GE HealthCare's Chief People Officer, Adam Y. Holton, was granted 5,457 restricted stock units and 14,348 employee stock options.
NASDAQ
GE HealthCare's Chief Accounting Officer, George A. Newcomb, increased his beneficial ownership through new restricted stock unit and employee stock option awards.
NASDAQ
GE HealthCare Technologies Inc. CEO Kevin Michael O'Neill received an award of 6,549 restricted stock units and 17,218 employee stock options.
NASDAQ
Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., was granted 9,356 restricted stock units and 24,598 employee stock options.